Cue Biopharma (CUE) announced the appointment of Shao-Lee Lin as CEO president and director. Lin will succeed Lucinda Warren, interim president and CEO. Prior to joining Cue, Lin was founder and CEO of Acelyrin.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: